JS
Janani Sambath
Institute of Bioinformatics
Research areas: Medicine · Oncology · Cancer Genomics and Diagnostics · Advanced Proteomics Techniques and Applications · Cancer Cells and Metastasis
Employment
-
Institute of Bioinformatics Ph.D Student2018 - Present
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (15)
- Gingivobuccal Squamous Cell Carcinoma Save
- Integrated genomic and proteomic profiling reveals insights into chemoradiation resistance in cervical cancer Save
- Liquid biopsy- A pivotal test to help navigate clinical decisions at a precision center in India! Save
- Phosphoproteomics guides low dose drug combination of cisplatin and silmitasertib against concurrent chemoradiation resistant cervical cancer Save
- Whole exome sequencing uncovers HRAS mutations as potential mediators of resistance to metronomic chemotherapy Save
- Erratum: Liquid biopsy and multi-analyte testing guided treatment of HER2 positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy (Oncotarget. (2020) 11 (4195–4200) DOI: 10.18632/oncotarget.27793) Save
- Pan-cancer quantitation of epithelial-mesenchymal transition dynamics using parallel reaction monitoring-based targeted proteomics approach Save
- Snail maintains the stem/progenitor state of skin epithelial cells and carcinomas through the autocrine effect of matricellular protein Mindin Save
- Circulating markers in metastatic cancer: new perspectives Save
- Excellent response with alpelisib and bicalutamide for advanced salivary duct carcinoma with PIK3CA mutation and high androgen receptor expression-A case report Save
- Snail maintains the stem/progenitor state of skin epithelial cells and carcinomas through the autocrine effect of the matricellular protein Mindin Save
- A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancer Save
- A commentary on outcomes with liquid biopsy to determine the epidermal growth factor receptor mutation status in poor performance status, biopsy-ineligible, advanced non-small cell lung cancer patients Save
- Bioinformatics analysis of global proteomic and phosphoproteomic data sets revealed activation of NEK2 and AURKA in cancers Save
- Liquid biopsy and multi-analyte testing guided treatment of HER2 positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy Save